• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾南部产毒临床分离株中艰难梭菌核糖体分型017和078占优势

Predominance of Clostridium difficile Ribotypes 017 and 078 among Toxigenic Clinical Isolates in Southern Taiwan.

作者信息

Hung Yuan-Pin, Huang I-Hsiu, Lin Hsiao-Ju, Tsai Bo-Yang, Liu Hsiao-Chieh, Liu Hsiu-Chuan, Lee Jen-Chieh, Wu Yi-Hui, Tsai Pei-Jane, Ko Wen-Chien

机构信息

Department of Internal Medicine, Tainan Hospital, Ministry of Health & Welfare, Tainan, Taiwan.

Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.

出版信息

PLoS One. 2016 Nov 18;11(11):e0166159. doi: 10.1371/journal.pone.0166159. eCollection 2016.

DOI:10.1371/journal.pone.0166159
PMID:27861606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5115699/
Abstract

Ribotypes and toxin genotypes of clinical C. difficile isolates in Taiwan are rarely reported. A prospective surveillance study from January 2011 to January 2013 was conducted at the medical wards of a district hospital in southern Taiwan. Of the first toxigenic isolates from 120 patients, 68 (56.7%) of 120 isolates possessed both tcdA and tcdB. Of 52 (43.3%) with tcdB and truncated tcdA (tcdA-/tcdB+), all were ribotype 017 and none had binary toxin or tcdC deletion. Eighteen (15%) toxigenic isolates harbored binary toxins (cdtA and cdtB) and all had tcdC deletion, including Δ39 (C184T) deletion (14 isolates), Δ18 in-frame deletion (3 isolates), and Δ18 (Δ117A) deletion (1 isolate). Eleven of 14 isolates with Δ39 (C184T) deletion belonged to the ribotype 078 family, including ribotype 127 (6 isolates), ribotype 126 (4 isolates), and ribotype 078 (1 isolate). Among 8 patients with consecutive C. difficile isolates, these isolates from 6 (75%) patients were identical, irrespective of the presence or absence of diarrhea, suggestive of persistent fecal carriage or colonization. In conclusion in southern Taiwan, ribotype 017 isolates with a tcdA-/tcdB+ genotype were not uncommon and of C. difficile isolates with binary toxin, the ribotype 078 family was predominant.

摘要

台湾临床艰难梭菌分离株的核糖型和毒素基因型鲜有报道。2011年1月至2013年1月在台湾南部一家地区医院的内科病房开展了一项前瞻性监测研究。在120例患者的首批产毒分离株中,120株中有68株(56.7%)同时具有tcdA和tcdB。在52株(43.3%)具有tcdB和截短型tcdA(tcdA-/tcdB+)的菌株中,均为核糖型017,无一株具有二元毒素或tcdC缺失。18株(15%)产毒分离株携带二元毒素(cdtA和cdtB),且均有tcdC缺失,包括Δ39(C184T)缺失(14株)、Δ18框内缺失(3株)和Δ18(Δ117A)缺失(1株)。14株具有Δ39(C184T)缺失的菌株中有11株属于核糖型078家族,包括核糖型127(6株)、核糖型126(4株)和核糖型078(1株)。在8例有连续艰难梭菌分离株的患者中,6例(75%)患者的这些分离株相同,无论有无腹泻,提示粪便持续携带或定植。总之,在台湾南部,tcdA-/tcdB+基因型的核糖型017分离株并不少见,在携带二元毒素的艰难梭菌分离株中,核糖型078家族占主导。

相似文献

1
Predominance of Clostridium difficile Ribotypes 017 and 078 among Toxigenic Clinical Isolates in Southern Taiwan.台湾南部产毒临床分离株中艰难梭菌核糖体分型017和078占优势
PLoS One. 2016 Nov 18;11(11):e0166159. doi: 10.1371/journal.pone.0166159. eCollection 2016.
2
Clostridium difficile ribotype 126 in southern Taiwan: a cluster of three symptomatic cases.台湾南部的艰难梭菌核糖体分型126:三例有症状病例的聚集
Anaerobe. 2014 Dec;30:188-92. doi: 10.1016/j.anaerobe.2014.06.005. Epub 2014 Jun 21.
3
New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.用于检测艰难梭菌毒素A(tcdA)、毒素B(tcdB)及二元毒素(cdtA/cdtB)基因的新型多重PCR方法应用于丹麦菌株库。
Clin Microbiol Infect. 2008 Nov;14(11):1057-64. doi: 10.1111/j.1469-0691.2008.02092.x.
4
First report of Clostridium difficile NAP1/027 in a Mexican hospital.墨西哥一家医院艰难梭菌NAP1/027的首次报告。
PLoS One. 2015 Apr 27;10(4):e0122627. doi: 10.1371/journal.pone.0122627. eCollection 2015.
5
Potentially hypervirulent Clostridium difficile PCR ribotype 078 lineage isolates in pigs and possible implications for humans in Taiwan.台湾猪体内潜在的高毒力艰难梭菌PCR核糖体分型078谱系分离株及其对人类的潜在影响
Int J Med Microbiol. 2016 Feb;306(2):115-22. doi: 10.1016/j.ijmm.2016.02.002. Epub 2016 Feb 12.
6
[Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].[2001年至2007年在让-韦迪耶-勒内-米雷医院分离出的艰难梭菌菌株的流行病学研究]
Pathol Biol (Paris). 2008 Nov-Dec;56(7-8):412-6. doi: 10.1016/j.patbio.2008.07.009. Epub 2008 Oct 7.
7
First isolation of Clostridium difficile PCR-ribotype 027/toxinotype III in Poland.波兰首次分离出艰难梭菌PCR核糖体分型027/毒素分型III。
Pol J Microbiol. 2008;57(3):267-8.
8
Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea.对从韩国12家医院分离出的艰难梭菌的毒素基因多样性、分子流行病学及抗菌药物耐药性的调查。
Korean J Lab Med. 2010 Oct;30(5):491-7. doi: 10.3343/kjlm.2010.30.5.491.
9
Distribution of Clostridium difficile PCR ribotypes in regions of Hungary.匈牙利各地区艰难梭菌PCR核糖体分型的分布情况。
J Med Microbiol. 2006 Mar;55(Pt 3):279-282. doi: 10.1099/jmm.0.46141-0.
10
Assessment of changes in the epidemiology of Clostridium difficile isolated from diarrheal patients in Hungary.评估匈牙利腹泻患者中分离出的艰难梭菌的流行病学变化。
Anaerobe. 2009 Dec;15(6):237-40. doi: 10.1016/j.anaerobe.2009.01.010. Epub 2009 Feb 9.

引用本文的文献

1
Potential effectiveness of parenteral nemonoxacin in the treatment of infections: , , and mouse studies.静脉注射奈诺沙星治疗感染的潜在有效性:体外、体内和小鼠研究。
Front Microbiol. 2024 Aug 20;15:1418817. doi: 10.3389/fmicb.2024.1418817. eCollection 2024.
2
Toxin genotypes, antibiotic resistance and their correlations in Clostridioides difficile isolated from hospitals in Xi'an, China.中国西安医院分离的艰难梭菌的毒素基因型、抗生素耐药性及其相关性。
BMC Microbiol. 2024 May 23;24(1):177. doi: 10.1186/s12866-024-03327-z.
3
Transcriptomic analysis of biofilm formation in strains of Clostridioides difficile associated with recurrent and non-recurrent infection reveals potential candidate markers for recurrence.

本文引用的文献

1
Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.入院时检测和隔离艰难梭菌携带者对艰难梭菌感染发生率的影响:一项准实验对照研究。
JAMA Intern Med. 2016 Jun 1;176(6):796-804. doi: 10.1001/jamainternmed.2016.0177.
2
Clostridium difficile Infection in Long-term Care Facilities: A Call to Action for Antimicrobial Stewardship.长期护理机构中的艰难梭菌感染:抗菌药物管理的行动呼吁。
Clin Infect Dis. 2015 May 15;60 Suppl 2:S72-6. doi: 10.1093/cid/civ053.
3
Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China.
艰难梭菌相关菌株生物膜形成的转录组分析揭示了复发感染的潜在候选标志物。
PLoS One. 2023 Aug 3;18(8):e0289593. doi: 10.1371/journal.pone.0289593. eCollection 2023.
4
Diversity of binary toxin positive Clostridioides difficile in Korea.韩国产双歧杆菌阳性艰难梭菌的多样性。
Sci Rep. 2023 Jan 11;13(1):576. doi: 10.1038/s41598-023-27768-0.
5
Bezlotoxumab prevents extraintestinal organ damage induced by infection.贝洛妥珠单抗可预防 感染引起的肠道外器官损伤。
Gut Microbes. 2022 Jan-Dec;14(1):2117504. doi: 10.1080/19490976.2022.2117504.
6
An Update on Binary Toxin.二元毒素更新
Toxins (Basel). 2022 Apr 27;14(5):305. doi: 10.3390/toxins14050305.
7
Temporal Variations in Patterns of Strain Diversity and Antibiotic Resistance in Thailand.泰国菌株多样性和抗生素耐药性模式的时间变化
Antibiotics (Basel). 2021 Jun 13;10(6):714. doi: 10.3390/antibiotics10060714.
8
Murine Intrarectal Instillation of Purified Recombinant Toxins Enables Mechanistic Studies of Pathogenesis.经纯化的重组毒素经直肠内灌注小鼠可用于发病机制的机制研究。
Infect Immun. 2021 Mar 17;89(4). doi: 10.1128/IAI.00543-20.
9
infection damages colonic stem cells via TcdB, impairing epithelial repair and recovery from disease.感染通过 TcdB 损害结肠干细胞,损害上皮修复并阻碍疾病恢复。
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):8064-8073. doi: 10.1073/pnas.1915255117. Epub 2020 Mar 20.
10
ribotype 017 - characterization, evolution and epidemiology of the dominant strain in Asia.ribotype 017-亚洲主要流行株的特征、进化和流行病学研究。
Emerg Microbes Infect. 2019;8(1):796-807. doi: 10.1080/22221751.2019.1621670.
住院癌症患者艰难梭菌携带情况:中国东部的一项前瞻性调查
BMC Infect Dis. 2014 Sep 29;14:523. doi: 10.1186/1471-2334-14-523.
4
The first case of severe Clostridium difficile ribotype 027 infection in Taiwan.台湾首例严重艰难梭菌核糖体分型027感染病例。
J Infect. 2015 Jan;70(1):98-101. doi: 10.1016/j.jinf.2014.08.003. Epub 2014 Aug 21.
5
Clostridium difficile ribotype 126 in southern Taiwan: a cluster of three symptomatic cases.台湾南部的艰难梭菌核糖体分型126:三例有症状病例的聚集
Anaerobe. 2014 Dec;30:188-92. doi: 10.1016/j.anaerobe.2014.06.005. Epub 2014 Jun 21.
6
Clinical characteristics of relapses and re-infections in Clostridium difficile infection.艰难梭菌感染中复发和再感染的临床特征。
Clin Microbiol Infect. 2014 Nov;20(11):1198-204. doi: 10.1111/1469-0691.12704. Epub 2014 Jul 18.
7
Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.粪便中产毒艰难梭菌定植的住院成年患者中艰难梭菌相关性腹泻的危险因素。
J Microbiol Immunol Infect. 2015 Apr;48(2):183-9. doi: 10.1016/j.jmii.2013.08.003. Epub 2013 Sep 21.
8
Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure.产毒或非产毒艰难梭菌定植的危险因素:Toll 样受体多态性和先前抗生素暴露的影响。
PLoS One. 2013 Jul 25;8(7):e69577. doi: 10.1371/journal.pone.0069577. Print 2013.
9
Molecular epidemiology of Clostridium difficile infection in a major chinese hospital: an underrecognized problem in Asia?艰难梭菌感染的分子流行病学研究:亚洲的一个被忽视的问题?
J Clin Microbiol. 2013 Oct;51(10):3308-13. doi: 10.1128/JCM.00587-13. Epub 2013 Jul 31.
10
Epidemiology of Clostridium difficile infection in Asia.亚洲艰难梭菌感染的流行病学。
Antimicrob Resist Infect Control. 2013 Jul 1;2(1):21. doi: 10.1186/2047-2994-2-21.